| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author index
|
|
|
|
84 |
S |
p. 208-214
|
artikel
|
| 2 |
Front Matter
|
|
|
|
84 |
S |
p. 1-9
|
artikel
|
| 3 |
O29 A comparison of human leukocyte antigen antibody profiles between circulating and reactivated memory B cells
|
Cheong, M.
|
|
|
84 |
S |
p. 46
|
artikel
|
| 4 |
O11 A computational HLA allele-typing protocol to de-noise and leverage nanopore amplicon data
|
Siddiqui, J.K.
|
|
|
84 |
S |
p. 25
|
artikel
|
| 5 |
O14 A novel multiplex digital PCR technology for accurate and rapid chimerism testing
|
Lara-Ospina, T.
|
|
|
84 |
S |
p. 29
|
artikel
|
| 6 |
O27 A web-based visualization tool for asymmetric linkage disequilibrium (ALD) between amino acid positions of classical HLA loci in US populations
|
Biagini, D.
|
|
|
84 |
S |
p. 43-44
|
artikel
|
| 7 |
O25 B cell FCXM, we[StQuote]ve been doing it wrong all along
|
Li, M.
|
|
|
84 |
S |
p. 41
|
artikel
|
| 8 |
O32 Bioinformatic segregation of chimeric libraries enables accurate donor HLA typing from allograft biopsies by ONT
|
Mosbruger, T.
|
|
|
84 |
S |
p. 49
|
artikel
|
| 9 |
O39 Characterization of HLA expression on memory-like (ML) NK cells
|
Maiers, M.
|
|
|
84 |
S |
p. 56
|
artikel
|
| 10 |
O36 Circulating T follicular helper cells are present and correlate with antibody-secreting B cells in liver transplant patients with ischemia-reperfusion injury
|
Bhat, A.
|
|
|
84 |
S |
p. 53
|
artikel
|
| 11 |
O7 Combining allele-specific solvent-accessible surface-protruding amino acid mismatches and predicted indirect T cell epitopes improves HLA matching in predicting kidney graft survival
|
Niemann, M.
|
|
|
84 |
S |
p. 20-21
|
artikel
|
| 12 |
O10 Common, intermediate, well-documented and rare HLA eplets in the world population: epCIWDR version 1.0.0
|
Ellison, M.A.
|
|
|
84 |
S |
p. 24
|
artikel
|
| 13 |
O24 Crosstalk between HLA class I and TLR4 mediates pro-inflammatory signaling cascades in endothelial cells via TLR4/MyD88 pathway
|
Jin, Y.
|
|
|
84 |
S |
p. 40
|
artikel
|
| 14 |
O35 Detection of circulating HLA-E in cancer patients: Potential application in cancer immunotherapy
|
Kanangat, V.
|
|
|
84 |
S |
p. 51-52
|
artikel
|
| 15 |
O19 Differential pairing of transmembrane domain GxxxG dimerization motifs generates two HLA-DR conformers defined by selective binding by the mAb Tü36
|
Hahn, A.
|
|
|
84 |
S |
p. 34
|
artikel
|
| 16 |
O2 Donor endothelial activation by serum from mismatched recipients
|
Shi, Q.S.
|
|
|
84 |
S |
p. 12-13
|
artikel
|
| 17 |
O22 Effector memory and TH17 CD4+ T cells are increased in liver transplant patients experiencing ischemia-reperfusion injury
|
Bhat, A.
|
|
|
84 |
S |
p. 39
|
artikel
|
| 18 |
O3 Endothelial cells exhibit an imbalance in classical, non-classical and accessory HLA molecule expression
|
Valenzuela, N.M.
|
|
|
84 |
S |
p. 14-15
|
artikel
|
| 19 |
O21 Estimating rates of immunologically incompatible organ offers caused by use of antigen-level deceased donor HLA typing for allocation
|
Gragert, L.
|
|
|
84 |
S |
p. 37-38
|
artikel
|
| 20 |
O5 Extensive organ-specific heterogeneity of HLA expression in endothelial cells
|
Valenzuela, N.M.
|
|
|
84 |
S |
p. 17-18
|
artikel
|
| 21 |
O38 Global coverage for iPSC banks: Balancing equity and volume
|
Maiers, M.
|
|
|
84 |
S |
p. 55
|
artikel
|
| 22 |
O1 Heart after liver transplant with domino liver (HALT-D) for a high CPRA patient
|
Gimferrer, I.
|
|
|
84 |
S |
p. 10-11
|
artikel
|
| 23 |
O18 Hemagglutination assay limits access to ABO-A2 kidney Transplantation
|
Halpin, A.M.
|
|
|
84 |
S |
p. 33-34
|
artikel
|
| 24 |
O33 HLA common null allele detection using a fast and easy CRISPR-Cas assay
|
van Wageningen, S.
|
|
|
84 |
S |
p. 50
|
artikel
|
| 25 |
O8 HLA-DQ promiscuity across loci?
|
Armstrong Antunes, A.
|
|
|
84 |
S |
p. 22
|
artikel
|
| 26 |
O17 HLA genotype imputation results in largely accurate epitope mismatch risk categorization across racial groups
|
Cohen, G.
|
|
|
84 |
S |
p. 32
|
artikel
|
| 27 |
O37 HLA-L pseudogene as a potential microRNA sponge for regulation of HLA-B
|
Chitnis, N.
|
|
|
84 |
S |
p. 54
|
artikel
|
| 28 |
O34 HLA-typing using a long-read HLA capture method combined with ONT or PacBio sequencing
|
Rijkers, M.
|
|
|
84 |
S |
p. 50
|
artikel
|
| 29 |
O12 Identification of DRB1 and DQB1 amino acid variability within serologic antigen groups
|
Brown, N.
|
|
|
84 |
S |
p. 25-27
|
artikel
|
| 30 |
O9 Impact of induction on acute rejection in kidney transplant recipients with high and low risk class II eplet mismatches
|
Tran, J.
|
|
|
84 |
S |
p. 22-23
|
artikel
|
| 31 |
O28 Interrogating DSA IgG characteristics and effector functions in lung transplant recipients
|
Harnois, M.
|
|
|
84 |
S |
p. 45-46
|
artikel
|
| 32 |
O23 NGS HLA typing reveals low-level maternal T cell engraftment through the detection of an unexpected DRB4
|
Bunin, N.
|
|
|
84 |
S |
p. 40
|
artikel
|
| 33 |
O20 Presumed or functional epitope: The need for confirmation with cell-based assays
|
Xu, Q.
|
|
|
84 |
S |
p. 35-36
|
artikel
|
| 34 |
O30 Site-directed mutagenesis of HLA-DQ molecules reveals the amino acids crucial for binding to human monoclonal HLA-specific antibody
|
Kramer, C.
|
|
|
84 |
S |
p. 47
|
artikel
|
| 35 |
O6 Substitution of glutamic acid at position 71 of DRΒ1*04:01 eliminates collagen sensitivity without inducing alloreactivity
|
Roark, C.L.
|
|
|
84 |
S |
p. 19
|
artikel
|
| 36 |
O40 Technology advancement in getting donor HLA information from recipient with unknown donor typing
|
Ho, J.C.
|
|
|
84 |
S |
p. 56-57
|
artikel
|
| 37 |
O13 The accuracy of eplet mismatching using imputed intermediate resolution HLA typing
|
Ge, S.
|
|
|
84 |
S |
p. 28
|
artikel
|
| 38 |
O26 The performance of a research hybrid-capture NGS assay for high-resolution HLA typing
|
Shen, M.
|
|
|
84 |
S |
p. 41-42
|
artikel
|
| 39 |
O4 The transcriptional repressor BCL6 selectively restrains expression of HLA class II and antigen presentation machinery in endothelial cells
|
Franco-Acevedo, A.
|
|
|
84 |
S |
p. 16
|
artikel
|
| 40 |
O16 Toward a combined DR+DQ HLA molecular mismatch score for risk stratification of pediatric heart transplant patients
|
Mangiola, M.
|
|
|
84 |
S |
p. 30-31
|
artikel
|
| 41 |
O31 Use of multiplexed, digital PCR to assess cellular chimerism and HLA loss of heterozygosity following allogeneic stem cell transplantation
|
Mak, C.
|
|
|
84 |
S |
p. 48
|
artikel
|
| 42 |
O15 Validation of wipe testing using the AlloSeq HCT platform
|
Williams, S.M.
|
|
|
84 |
S |
p. 29
|
artikel
|
| 43 |
P611 A case of complex HLA typing using a buccal swab from a patient after two hematopoietic cell transplants
|
Shen, M.
|
|
|
84 |
S |
p. 167
|
artikel
|
| 44 |
P516 A case of false positive Class II antibody reactivity consistent in both the One Lambda and Immucor Luminex single-antigen bead (SAB) assays
|
Muluhngwi, P.
|
|
|
84 |
S |
p. 140
|
artikel
|
| 45 |
P612 A comparison of the LinkSeq SABR and QType 11 real-time PCR genotyping assays
|
Sherrill, J.
|
|
|
84 |
S |
p. 168
|
artikel
|
| 46 |
P209 Adsorption/elution experiments reveal that 166DG and 166ES eplets cross-react
|
Martins Lima, A.
|
|
|
84 |
S |
p. 93-94
|
artikel
|
| 47 |
P617 Alloimmune endotypes and related outcomes in human liver transplantation
|
Sosa, R.A.
|
|
|
84 |
S |
p. 174-175
|
artikel
|
| 48 |
P518 Ambiguous single antigen beads testing results: Impact on virtual crossmatch assessment and guide for resolution
|
Nasse, C.
|
|
|
84 |
S |
p. 141
|
artikel
|
| 49 |
P113 Amino acid based surrogate allele selection within virtual crossmatch
|
Brack, C.
|
|
|
84 |
S |
p. 70
|
artikel
|
| 50 |
P515 An allele-specific DQA1 antibody directed against an Exon 3 polymorphism
|
Morris, A.B.
|
|
|
84 |
S |
p. 138-139
|
artikel
|
| 51 |
P116 An R program for automatic quality control of single antigen bead assays via Levey-Jennings charts
|
Kamieniecki, E.
|
|
|
84 |
S |
p. 72-73
|
artikel
|
| 52 |
P107 An unusual association of DR7 AND DQ8 in Saudi people
|
Mohammed, A.
|
|
|
84 |
S |
p. 65
|
artikel
|
| 53 |
P615 A potential role of non-HLA antibodies in renal allograft rejection
|
Keen, J.
|
|
|
84 |
S |
p. 172-173
|
artikel
|
| 54 |
P501 A rare association of DRB1*08:04, DQB1*03:19, and DRB3*01:62 in a cord-blood unit; A case study
|
Lemieux, W.
|
|
|
84 |
S |
p. 124
|
artikel
|
| 55 |
P115 Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods
|
Brow, D.
|
|
|
84 |
S |
p. 71
|
artikel
|
| 56 |
P521 Assessment of HLA-associated type 1 diabetes risk in Haiti
|
Noble, J.A.
|
|
|
84 |
S |
p. 145
|
artikel
|
| 57 |
P712 Assessment of human leukocyte antigen typing and chimerism testing combined on a single next generation sequencing run
|
Willis, A.
|
|
|
84 |
S |
p. 193
|
artikel
|
| 58 |
P517 Assessment of the effect of UNOS new CPRA calculator, implemented in January 2023, on sensitized kidney and pancreas patient population at Cedars Sinai Medical Center
|
Naim, M.
|
|
|
84 |
S |
p. 140
|
artikel
|
| 59 |
P218 Association of HLA-DRB1*04 with acute severe hepatitis of unknown aetiology in children: Results from an Irish cohort
|
Hickey, C.
|
|
|
84 |
S |
p. 99
|
artikel
|
| 60 |
P721 Back to the future: Serological characterization of the HLA-C*17:03 allele
|
Zhang, A.
|
|
|
84 |
S |
p. 205-206
|
artikel
|
| 61 |
P711 Back to the future: The MHC complement genes revisited in transplant and disease
|
Wang, T.
|
|
|
84 |
S |
p. 193
|
artikel
|
| 62 |
P606 Basecalling accuray of HLA loci using rapid Nanopore sequencing
|
Reiling, S.J.
|
|
|
84 |
S |
p. 160
|
artikel
|
| 63 |
P202 Belimumab causes positive B cell flow cytometric crossmatches with untreated lymphocytes but not with pronase-treated lymphocytes
|
Fang, D.C.
|
|
|
84 |
S |
p. 88
|
artikel
|
| 64 |
P613 Beware of false negative virtual crossmatches in a culturally diverse pool of deceased donors
|
Shin, H.
|
|
|
84 |
S |
p. 169
|
artikel
|
| 65 |
P103 Characterization of HLA-OLI and HLA-Y allele and haplotype diversity from whole genome trios
|
Alexandrov, N.
|
|
|
84 |
S |
p. 62
|
artikel
|
| 66 |
P522 Characterization of linkage disequilibrium between DRB1*01 and DRB5
|
Norvell, B.
|
|
|
84 |
S |
p. 145-146
|
artikel
|
| 67 |
P104 Clinical validation of next generation sequencing-based engraftment monitoring for pediatric patients after hematopoietic cell transplantation
|
Chi, L.
|
|
|
84 |
S |
p. 62
|
artikel
|
| 68 |
P201 Comparison and evaluation of MFI values between five HLA labs
|
Enten, H.
|
|
|
84 |
S |
p. 87
|
artikel
|
| 69 |
P121 Correlation of HLA epitope mismatches with de novo donor-specific antibody formation in renal transplant recipients – A comparison of snowflake to HLAMatchmaker and PIRCHE scores
|
Chou-Wu, E.
|
|
|
84 |
S |
p. 80
|
artikel
|
| 70 |
P525 Cracking the code: Exploring the connection between COVID-19 vaccines and HLA antibodies in kidney transplant candidates
|
Webster, D.
|
|
|
84 |
S |
p. 149-150
|
artikel
|
| 71 |
P526 CREG associations and epitope analyses should not be overlooked when performing virtual crossmatch
|
Pandey, S.
|
|
|
84 |
S |
p. 151
|
artikel
|
| 72 |
P225 Daratumumab-induced interference with HLA crossmatching in cardiac amyloidosis patients awaiting heart transplantation
|
Lee, J.
|
|
|
84 |
S |
p. 107
|
artikel
|
| 73 |
P519 Deciphering the loss of anti-angiotensin type 1 receptor reactivity in enzyme-linked immunosorbent assay post-adsorption
|
Nguyen, J.T.
|
|
|
84 |
S |
p. 142-143
|
artikel
|
| 74 |
P524 Defining novel HLA serological specificities using a large clinical data of single antigen bead assay
|
Osoegawa, K.
|
|
|
84 |
S |
p. 147-148
|
artikel
|
| 75 |
P228 De novo anti-HLA donor-specific antibodies not diagnostic for ABMR are associated with a higher risk of persistent/recurrent TCMR and graft dysfunction in kidney transplant patients
|
Juma, Y.S.
|
|
|
84 |
S |
p. 111
|
artikel
|
| 76 |
P510 Description of a novel HLA-DQαβ epitope formed by two self-residues and validated by adsorption/elution
|
Martins Lima, A.
|
|
|
84 |
S |
p. 134-135
|
artikel
|
| 77 |
P504 Differentiating among allele-specific antibodies is important for a successful heart transplantation
|
Liu, J.
|
|
|
84 |
S |
p. 127
|
artikel
|
| 78 |
P706 Discordant virtual and flow crossmatch: Prozone with Adsorb-Out analysis
|
Portwood, E.
|
|
|
84 |
S |
p. 188-189
|
artikel
|
| 79 |
P214 Donor-specific antibodies (DSA) in liver transplantation: Should DSA be considered?
|
Helander, L.
|
|
|
84 |
S |
p. 97
|
artikel
|
| 80 |
P610 Donor specific antibodies (DSA) monitoring: The effect of clinical decision support (CDS) intervention on DSA orders
|
Scalf, C.
|
|
|
84 |
S |
p. 166
|
artikel
|
| 81 |
P230 Donor-specific HLA antibody characteristics at the time of biopsy with and without antibody-mediated rejection in kidney transplantation
|
Kaneku, H.
|
|
|
84 |
S |
p. 114
|
artikel
|
| 82 |
P106 DP mischievous: Case reports of isolated de nove DP donor specific antibodies
|
Awaji, M.
|
|
|
84 |
S |
p. 63-64
|
artikel
|
| 83 |
P500 Effects of donor-specific human leukocyte antigen and non-human leukocyte antigen antibodies on antibody-mediated rejection in renal transplant recipients
|
Lee, H.
|
|
|
84 |
S |
p. 123
|
artikel
|
| 84 |
P720 Engraftment and minimal residual disease monitoring after stem cell transplantation: Comparison of next-generation sequencing vs. a combination of short tandem repeats and quantitative PCR
|
Zhang, A.
|
|
|
84 |
S |
p. 204
|
artikel
|
| 85 |
P710 Engraftment of liver donor derived hematopoietic stem cells in a patient with a history of hematopoietic stem cell transplant
|
Walker, S.
|
|
|
84 |
S |
p. 191-192
|
artikel
|
| 86 |
P602 Evaluation of alternative SPRI beads for a multiplex 11-loci HLA genotyping assay NGS library preparation workflow
|
Ramirez, M.
|
|
|
84 |
S |
p. 154
|
artikel
|
| 87 |
P203 Evaluation of a modified NGS library preparation workflow for HLA genotyping
|
Ferguson, G.B.
|
|
|
84 |
S |
p. 89
|
artikel
|
| 88 |
P200 Evaluation of PreSorb beads in removing nonspecific reactivities in HLA antibody test by luminex solid phase single antigen beads assay
|
Kendrick, J.
|
|
|
84 |
S |
p. 86
|
artikel
|
| 89 |
P620 Expanding the horizon to find the uncharted. Using the extended SAB panel to improve HLA antibody assignment and identify new eplet in a kidney transplanted patient
|
Liwski, R.
|
|
|
84 |
S |
p. 177
|
artikel
|
| 90 |
P400 Extending a virtual crossmatch analysis and reporting workflow to include HLA eplet mismatch load with risk stratification for post transplant kidney clinical decision support
|
Morlen, R.
|
|
|
84 |
S |
p. 121
|
artikel
|
| 91 |
P507 Frequency of immunizing HLA epitopes and immungenicity: A new approach to immunological risk assessment?
|
MarElia-Bennett, C.
|
|
|
84 |
S |
p. 131
|
artikel
|
| 92 |
P614 From positive VXM to negative PXM: How to proceed?
|
Skaljic, I.
|
|
|
84 |
S |
p. 170-171
|
artikel
|
| 93 |
P616 Gene target enrichment by hybrid capture vs long-range polymerase chain reaction methods for routine high-resolution genotyping
|
Gomes, E.
|
|
|
84 |
S |
p. 174
|
artikel
|
| 94 |
P605 Genotyping discrepancies in different tests in a relapsed stem cell recipient
|
Reiling, S.J.
|
|
|
84 |
S |
p. 159
|
artikel
|
| 95 |
P700 Going, going…gone and transplanted! An OPO lab’s perspective since the March 2021 UNOS kidney allocation changes
|
Tanner, K.
|
|
|
84 |
S |
p. 181-182
|
artikel
|
| 96 |
P506 HCT donor age in relation to patients[StQuote] HLA genotype frequency
|
Madbouly, A.
|
|
|
84 |
S |
p. 129-130
|
artikel
|
| 97 |
P122 High and low resolution-based HLA typing for PIRCHE analysis of molecular mismatch is comparable for prediction of DSA and rejection in kidney transplant recipients
|
Crane, C.
|
|
|
84 |
S |
p. 81-82
|
artikel
|
| 98 |
P514 High background challenges in single antigen bead assay
|
Morris, S.
|
|
|
84 |
S |
p. 137
|
artikel
|
| 99 |
P215 Highly sensitized HLA B46 homozygous patient that makes antibodies to Bw4 and Bw6 public epitopes
|
Hickey, M.
|
|
|
84 |
S |
p. 98
|
artikel
|
| 100 |
P511 High-resolution HLA analysis in 4,466 volunteers from Pará for the Brazilian Bone Marrow Registry
|
Mattos, P.
|
|
|
84 |
S |
p. 136
|
artikel
|
| 101 |
P708 HLA-A*24:353 haplotypes differ in Asian subpopulations
|
Lacelle, C.
|
|
|
84 |
S |
p. 190
|
artikel
|
| 102 |
P709 HLA Class I and II expression on T and B cells from deceased donor peripheral blood, lymph nodes and spleen: Is peripheral blood an equal specimen for physical crossmatch?
|
Wagenknecht, D.
|
|
|
84 |
S |
p. 191
|
artikel
|
| 103 |
P100 HLA-Cw epitope analysis can resolve positive physical flow cytometry crossmatch in absence of donor-specific antibodies and prozone effect – A case study
|
Abu-Khader, A.
|
|
|
84 |
S |
p. 58-59
|
artikel
|
| 104 |
P123 HLA diversity in Brazilian population: Detection of 48 new alleles by next-generation sequencing
|
da Silva, J.
|
|
|
84 |
S |
p. 83
|
artikel
|
| 105 |
P704 HLA-DR expression is absent in normal heart transplant biopsies but diffusely upregulated during acute rejection
|
Valenzuela, N.M.
|
|
|
84 |
S |
p. 186-187
|
artikel
|
| 106 |
P302 HLA haplo-identical: Yes or no
|
Chan, Y.
|
|
|
84 |
S |
p. 118-119
|
artikel
|
| 107 |
P705 HLA loss detection by NGS using a multiplex of 16 markers within the MHC region
|
Geerligs, J.
|
|
|
84 |
S |
p. 188
|
artikel
|
| 108 |
P226 How eplet analysis complements HLA antibody interpretation, flow and virtual crossmatching: A challenging case study
|
Ji, R.
|
|
|
84 |
S |
p. 107-108
|
artikel
|
| 109 |
P221 Identifying the specificity of non-HLA antibodies in flow cytometry crossmatch positive, HLA DSA negative patient sera
|
Jain, D.
|
|
|
84 |
S |
p. 102-103
|
artikel
|
| 110 |
P523 IgM DSA – Can they be detected before IgG DSA
|
Ong, G.D.
|
|
|
84 |
S |
p. 147
|
artikel
|
| 111 |
P703 Impact of a positive crossmatch with negative donor specific antibody on kidney transplantation
|
Vantair, N.
|
|
|
84 |
S |
p. 184-185
|
artikel
|
| 112 |
P206 Impact of class I and II HLA antigenic, allelic, and epitopic mismatches on acute rejection in kidney transplantation
|
de Marco, R.
|
|
|
84 |
S |
p. 91
|
artikel
|
| 113 |
P125 Impact of mutations at the autoimmune regulator gene on the modulation of histocompatibility genes in medullary thymic epithelial cell spheroids
|
Donadi, E.A.
|
|
|
84 |
S |
p. 85
|
artikel
|
| 114 |
P715 Impact of requiring HLA typing of heart transplant candidates on virtual crossmatch and DSA interpretation
|
Xin, J.J.
|
|
|
84 |
S |
p. 197
|
artikel
|
| 115 |
P402 Implementation of a high-throughput NGS-based HLA typing assay for celiac disease testing: validation and clinical experience
|
Lazar-Molnar, E.
|
|
|
84 |
S |
p. 122
|
artikel
|
| 116 |
P229 Improving monitoring and detection of engraftment in hematopoietic stem cell transplantation through next-generation sequencing (NGS) based chimerism testing: A robust validation study
|
Pearce, T.
|
|
|
84 |
S |
p. 112-113
|
artikel
|
| 117 |
P223 Increase in diversity of characteristics of novel alleles discovered after adoption of next-generation sequencing
|
Hu, Q.
|
|
|
84 |
S |
p. 104-105
|
artikel
|
| 118 |
P603 Increasing single antigen panel size has no impact on MFI values
|
Ray, B.
|
|
|
84 |
S |
p. 155-156
|
artikel
|
| 119 |
P105 In search of a tool to untangle complex antibody responses
|
Austin, D.
|
|
|
84 |
S |
p. 63
|
artikel
|
| 120 |
P112 Integrating the Oxford Nanopore MinION bioinformatic pipeline into an HLA laboratory information management system for high-resolution typing workflow
|
Brack, C.
|
|
|
84 |
S |
p. 70
|
artikel
|
| 121 |
P212 Investigating HLA-DQ immunogenicity in lung transplantation
|
Harnois, M.
|
|
|
84 |
S |
p. 96
|
artikel
|
| 122 |
P502 Investigating the effects of Rituximab and Obinutuzumab on cell flow cross-match and complement-dependent cytotoxicity cross-match assays in HLA laboratory settings
|
Li, F.
|
|
|
84 |
S |
p. 124
|
artikel
|
| 123 |
P119 Invisible ink: Some markers for copy-neutral loss-of-heterozygosity chimerism are only detectable when they disappear
|
Carter, M.
|
|
|
84 |
S |
p. 77-78
|
artikel
|
| 124 |
P101 Is routine physical crossmatch necessary? A single center, comparative analysis of virtual and physical crossmatch results
|
Achram, R.
|
|
|
84 |
S |
p. 60
|
artikel
|
| 125 |
P219 Kidney transplantation across pre-existing DSA using solely virtual crossmatch results
|
Hidalgo, L.G.
|
|
|
84 |
S |
p. 99-100
|
artikel
|
| 126 |
P102 Less is more: Decreasing pronase treatment time to expedite flow cytometric crossmatches without compromising B cell crossmatch results
|
Al Aufi, M.
|
|
|
84 |
S |
p. 60-61
|
artikel
|
| 127 |
P124 Like mother, not like daughter? Discovery of a novel DPA1 allele due to discrepant HLA typing between a patient and her daughter
|
Dijke, E.
|
|
|
84 |
S |
p. 83-84
|
artikel
|
| 128 |
P110 Long-range PCR and hybrid-capture methods for high-resolution HLA typing by NGS
|
Blouin, A.G.
|
|
|
84 |
S |
p. 69
|
artikel
|
| 129 |
P220 Managing STAT deceased donor HLA typing and laboratory staff shortage: Experience of two HLA laboratories
|
Hod Dvorai, R.
|
|
|
84 |
S |
p. 101
|
artikel
|
| 130 |
P118 Molecule of equivalent fluorochrome (MEF) as second method to validate Halifaster flow crossmatch results
|
Nicholson, I.
|
|
|
84 |
S |
p. 74-76
|
artikel
|
| 131 |
P509 Natural knockouts: HLA genotypes with no expressed alleles
|
Maiers, M.
|
|
|
84 |
S |
p. 133
|
artikel
|
| 132 |
P111 Navigating through discordant results towards a successful transplant
|
Rewinski, M.
|
|
|
84 |
S |
p. 69
|
artikel
|
| 133 |
P303 “Obscured” donor specific antibody in haplo-identical haematopoietic stem cell transplant
|
Tam, K.W.
|
|
|
84 |
S |
p. 120
|
artikel
|
| 134 |
P114 Patients with gout present frequent positive or questionable autologous and allogeneic crossmatches in the absence of positive donor specific antibodies
|
Bravo-Egana, V.
|
|
|
84 |
S |
p. 71
|
artikel
|
| 135 |
P707 Performance and evaluation of a novel NGS assay and software for monitoring dd-cfDNA following kidney transplantation
|
Pettersson, L.
|
|
|
84 |
S |
p. 190
|
artikel
|
| 136 |
P609 Performance of single antigen plus ExPlex and PRA bead assays in challenging cases of allo-hematopoietic cell transplant patients
|
Savchik, C.
|
|
|
84 |
S |
p. 164-165
|
artikel
|
| 137 |
P231 Persistence and pattern of islet antibodies among Type 1 diabetes patients from North India
|
Kanga, U.
|
|
|
84 |
S |
p. 115
|
artikel
|
| 138 |
P621 Phasing challenge- discovery and lesson-learned from an HCT case
|
Taha, N.
|
|
|
84 |
S |
p. 178
|
artikel
|
| 139 |
P503 Post stem cell transplant monitoring: Next generation sequencing for the assessment of chimerism on isolated cell subsets myeloid & lymphoid
|
Liacini, A.
|
|
|
84 |
S |
p. 125-126
|
artikel
|
| 140 |
P714 Profiles of cytokines during six months after kidney transplantation
|
Shi, Q.S.
|
|
|
84 |
S |
p. 195-196
|
artikel
|
| 141 |
P508 PY-ARD – A Swiss army knife of HLA assignments
|
Maiers, M.
|
|
|
84 |
S |
p. 132
|
artikel
|
| 142 |
P607 5Q deletion detected by STR testing
|
Roman, G.
|
|
|
84 |
S |
p. 161-162
|
artikel
|
| 143 |
P716 qPCR-based purity assessment of isolated cell subsets for lineage-specific chimerism test
|
Ye, F.
|
|
|
84 |
S |
p. 197-198
|
artikel
|
| 144 |
P126 Qualification of ABI instruments QuantStudio 6 Pro or QuantStudio 7 Pro for Olerup QTYPE 11 use
|
Wang, H.
|
|
|
84 |
S |
p. 85
|
artikel
|
| 145 |
P604 Rapid and accurate high-resolution HLA typing by Nanopore-based sequencing
|
Reiling, S.J.
|
|
|
84 |
S |
p. 157-158
|
artikel
|
| 146 |
P205 Rapid high-resolution HLA typing using Nanopore technology
|
Gareau, A.
|
|
|
84 |
S |
p. 91
|
artikel
|
| 147 |
P608 Recipient allelic imbalance in short tandem repeats chimerism testing indicates disease relapse
|
Ruth, R.
|
|
|
84 |
S |
p. 163
|
artikel
|
| 148 |
P718 Recipient buccal mucosa demonstrating 100% donor-derived DNA from chronic GVHD of oral cavity
|
Rozar, K.
|
|
|
84 |
S |
p. 202-203
|
artikel
|
| 149 |
P520 Repeated local ellipsoid protrusion supplements human leukocyte antigen surface characterization
|
Niemann, M.
|
|
|
84 |
S |
p. 144
|
artikel
|
| 150 |
P224 Reporting a rare KIR genotype lacking framework genes
|
Hu, T.
|
|
|
84 |
S |
p. 106
|
artikel
|
| 151 |
P300 Role of ExPlex HLA antibody panel in de novo HLA donor-specific antibody identification in kidney transplant recipients: 2 case reports
|
Kendrick, J.
|
|
|
84 |
S |
p. 115
|
artikel
|
| 152 |
P208 Scratching the surface: Pronase treatment does not reduce the expression of HLA on lymphocytes and improves the sensitivity of B cell flow cytometry crossmatch by reducing nonspecific background
|
de Marco, R.
|
|
|
84 |
S |
p. 92
|
artikel
|
| 153 |
P505 Serum pretreatment and the single antigen bead assay – A closer look
|
Locke, A.F.
|
|
|
84 |
S |
p. 128
|
artikel
|
| 154 |
P619 Serum reduction, a cost effective and efficient treatment to reduce non-specific binding in screening for anti-human leukocyte antigen (HLA) antibodies
|
Sunderhaus, E.R.
|
|
|
84 |
S |
p. 176
|
artikel
|
| 155 |
P713 Simple and efficient monitoring of HLA NGS amplicons with Olerup SSP®HLA wipe test
|
Li, C.
|
|
|
84 |
S |
p. 194
|
artikel
|
| 156 |
P601 Stem cell recipient becomes solid organ donor: Whose HLA is this?
|
Rafalko, M.
|
|
|
84 |
S |
p. 154
|
artikel
|
| 157 |
P120 Successful Daratumumab desensitization strategy in a highly sensitized heart transplant patient
|
Choi, S.
|
|
|
84 |
S |
p. 79
|
artikel
|
| 158 |
P401 Successful removal of flow cytometry crossmatch interference by a novel rituximab biosimilar
|
Lazar-Molnar, E.
|
|
|
84 |
S |
p. 121
|
artikel
|
| 159 |
P403 The adsorption crossmatch cells and elution (AXE) technique to identify true HLA specific antibodies
|
Leahy, R.
|
|
|
84 |
S |
p. 122
|
artikel
|
| 160 |
P623 The A24 mystery – The missing link between solid-phase and cell-based assays
|
Taniguchi, M.
|
|
|
84 |
S |
p. 179-180
|
artikel
|
| 161 |
P301 The clinical course of a pre-existing, weak DSA targeting HLA-DR
|
Hidalgo, L.G.
|
|
|
84 |
S |
p. 116-117
|
artikel
|
| 162 |
P717 The clinical significance and prevalence of allele-specific and unexpected serological findings in European and non-European transplant recipients
|
Yin, Y.
|
|
|
84 |
S |
p. 199-201
|
artikel
|
| 163 |
P109 The DRB4*03:01N allele confounds NGS typing software
|
Bell, D.
|
|
|
84 |
S |
p. 69
|
artikel
|
| 164 |
P227 The impact of de novo Class II donor specific antibody on combined liver/heart or liver/kidney transplant: Can the liver protect the second allograft?
|
Johnson, K.P.
|
|
|
84 |
S |
p. 109-110
|
artikel
|
| 165 |
P210 The impact of HLA-DPB1 disparity on clinical outcome post unrelated hematopoietic stem cell transplantation between 2016 and 2021 – A single center experience
|
Guan, Q.
|
|
|
84 |
S |
p. 95
|
artikel
|
| 166 |
P211 The Mayo Clinic Arizona virtual crossmatch algorithm supporting the largest solid organ transplant program in the United States
|
Hacke, K.
|
|
|
84 |
S |
p. 95
|
artikel
|
| 167 |
P117 To HLA B or not to B matched: B46 homozygous candidates sensitized against both Bw4 and Bw6 epitopes are disadvantaged in kidney allocation
|
Butler, C.
|
|
|
84 |
S |
p. 74
|
artikel
|
| 168 |
P513 Towards automated epitope analysis during virtual crossmatch
|
Morlen, R.
|
|
|
84 |
S |
p. 137
|
artikel
|
| 169 |
P701 Unconventional DSA found in histological antibody mediated rejection reported negative for antibody
|
Taverniti, A.
|
|
|
84 |
S |
p. 183
|
artikel
|
| 170 |
P618 Unexpected cross-reactivity of a previously characterized HLA-A1/A36 monoclonal antibody
|
Suh, D.
|
|
|
84 |
S |
p. 176
|
artikel
|
| 171 |
P622 Unidirectional graft-versus-host HLA mismatch in kidney transplants is not associated with post-transplant survival
|
Tang, M.
|
|
|
84 |
S |
p. 179
|
artikel
|
| 172 |
P512 Urine exosome mRNA-based test for monitoring kidney allograft rejection: Effects of sample transportation and storage, and interference substances
|
McFaul, M.
|
|
|
84 |
S |
p. 136
|
artikel
|
| 173 |
P204 Use of cell-free DNA analysis to determine need for renal transplant biopsy after detection of circulating donor-specific anti-HLA antibodies in renal transplant recipients
|
Gallay, B.J.
|
|
|
84 |
S |
p. 89-90
|
artikel
|
| 174 |
P222 Using epitope analysis to aid in test interpretation and to guide donor matching for a highly sensitized patient
|
Hu, Q.
|
|
|
84 |
S |
p. 104
|
artikel
|
| 175 |
P108 Utilization of HistoTrac® module for managing donor search in a high-volume hematopoietic cell transplant program
|
Bamert, R.
|
|
|
84 |
S |
p. 66-68
|
artikel
|
| 176 |
P127 Validation of HLA typing reagents and analysis software: Can we do better to prevent erroneous typing results?
|
Abu-Khader, A.
|
|
|
84 |
S |
p. 86
|
artikel
|
| 177 |
P702 Validation of Omixon NanoTYPE HLA typing using Oxford Nanopore Technologies (ONT)
|
Tian, R.
|
|
|
84 |
S |
p. 183
|
artikel
|
| 178 |
P207 Virtual crossmatch: Could all HLA-DQB1*03:01P antigens be analyzed in the same way?
|
Fantini, R.
|
|
|
84 |
S |
p. 92
|
artikel
|
| 179 |
P527 We have seen it all: Hemi-, homo-, hetero- and now tri-zygous HLA-DR – Unique case described in a healthy donor
|
Peton, B.
|
|
|
84 |
S |
p. 152
|
artikel
|
| 180 |
P600 When does a public epitope become private?
|
Pierce, K.L.
|
|
|
84 |
S |
p. 153
|
artikel
|
Tijdschrift beschrijving